Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells

Ex vivo gene therapy (GT) is a promising treatment for inherited genetic diseases. An ideal transduction protocol should determine high gene marking in long-term self-renewing hematopoietic stem cells (HSCs), preserving their repopulation potential during in vitro manipulation. In the context of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Poletti, Valentina, Montepeloso, Annita, Pellin, Danilo, Biffi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618226/
https://www.ncbi.nlm.nih.gov/pubmed/37920236
http://dx.doi.org/10.1016/j.omtm.2023.101131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618226/
https://www.ncbi.nlm.nih.gov/pubmed/37920236
http://dx.doi.org/10.1016/j.omtm.2023.101131

Ejemplares similares